Log in
Enquire now
‌

US Patent 11358994 Fatty acid modified human epidermal growth factor

Patent 11358994 was granted and assigned to Saint Louis University on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Saint Louis University
Saint Louis University
Current Assignee
Saint Louis University
Saint Louis University
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11358994
Patent Inventor Names
Peter G. Ruminski0
Marvin J. Meyers0
David C. Wood0
Stacy D. Arnett0
Matthew P. Yates0
Date of Patent
June 14, 2022
Patent Application Number
16633467
Date Filed
July 25, 2018
Patent Primary Examiner
‌
Marianne P Allen

The disclosure provides for new epidermal growth factor (EGF)-based reagents that have been modified by fatty acid conjugation. Method of using such agents to treatment Short Bowel Syndrome (SBS) are also described.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11358994 Fatty acid modified human epidermal growth factor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.